EFCAX
Price
$21.57
Change
-$0.27 (-1.24%)
Updated
Jun 13 closing price
Net Assets
21.31M
RGAHX
Price
$77.22
Change
-$0.93 (-1.19%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

EFCAX vs RGAHX

Header iconEFCAX vs RGAHX Comparison
Open Charts EFCAX vs RGAHXBanner chart's image
Emerald Insights A
Price$21.57
Change-$0.27 (-1.24%)
VolumeN/A
Net Assets21.31M
American Funds Growth Fund of Amer R5E
Price$77.22
Change-$0.93 (-1.19%)
VolumeN/A
Net Assets306.22B
EFCAX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EFCAX vs. RGAHX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFCAX is a Buy and RGAHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 306B vs. EFCAX (21.3M). RGAHX pays higher dividends than EFCAX: RGAHX (0.50) vs EFCAX (0.00). EFCAX was incepted earlier than RGAHX: EFCAX (11 years) vs RGAHX (10 years). EFCAX (2.03) is less costly to investors than RGAHX (0.44). EFCAX is a more actively managed with annual turnover of: 61.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than EFCAX: RGAHX (250) vs EFCAX (2000). EFCAX annual gain was more profitable for investors over the last year : 10.11 vs. RGAHX (7.38). EFCAX return over 5 years is better than : 61.33 vs. RGAHX (49.84).
EFCAXRGAHXEFCAX / RGAHX
Total Expense Ratio1.350.44307%
Annual Report Gross Expense Ratio2.030.44461%
Fund Existence11 years10 years-
Gain YTD2.2275.14743%
Front Load5%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets21.3M306B0%
Annual Yield % from dividends0.000.50-
Returns for 1 year10.117.38137%
Returns for 3 years60.8553.85113%
Returns for 5 years61.3349.84123%
Returns for 10 years89.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHX4.33N/A
N/A
PHX Minerals
ESE184.00-2.44
-1.31%
ESCO Technologies
CRL149.45-2.44
-1.61%
Charles River Laboratories International
STOK11.53-0.29
-2.45%
Stoke Therapeutics
SHPH0.13-0.01
-9.35%
Shuttle Pharmaceuticals Holdings Inc